Immuron (IMRN) Depreciation & Amortization - Total (2016 - 2018)
Immuron's quarterly Depreciation & Amortization - Total came in at -$2646.0 in Q4 2018, down 49.11% year-on-year from -$5199.2 in Q4 2017, and down 49.11% quarter-over-quarter from -$1774.6 in Q4 2017.
Immuron has reported Depreciation & Amortization - Total for 3 years, with the latest figure at -$2646.0 in Q4 2018.
- For the quarter ending Q4 2018, Depreciation & Amortization - Total fell 49.11% year-over-year to -$2646.0; the trailing twelve-month figure through Jun 2020 stood at -$2646.0 (changed 0.0% YoY), and the FY2025 full-year result was $32204.2, up 6.79% from the prior year.
- Depreciation & Amortization - Total for Q4 2018 stood at -$2646.0, down from -$1774.6 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was -$1489.1 in Q4 2016, with the low at -$2906.2 in Q2 2016.
- Average Depreciation & Amortization - Total over 3 years is -$2204.0, with a median of -$2210.3 recorded in 2018.
- Year-over-year, Depreciation & Amortization - Total retreated 19.17% in 2017 and slumped 49.11% in 2018.
- Tracing IMRN's Depreciation & Amortization - Total over 3 years: stood at -$1489.1 in 2016, then slipped by 19.17% to -$1774.6 in 2017, then tumbled by 49.11% to -$2646.0 in 2018.
- The last three Depreciation & Amortization - Total figures came in at -$2646.0 (Q4 2018), -$1774.6 (Q4 2017), and -$1489.1 (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -2,646.00 |
| Dec 31, 2017 | -1,774.56 |
| Dec 31, 2016 | -1,489.11 |
| Jun 30, 2016 | -2,906.17 |